The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
about
Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal modelsAgitation in the ICU: part one Anatomical and physiologic basis for the agitated statePregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activityCholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.Mechanisms mediating CCK-8S-induced contraction of proximal colon in guinea pigs.Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.Structure-based design in drug discovery--the application of a peptoid drug design strategy for the development of non-peptide neuropeptide receptor ligands.A sensitive high-performance liquid chromatographic assay for the cholecystokinin-B antagonist, CI-988, in human and monkey plasma.CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons.The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist.Benzodiazepine/cholecystokinin interactions at functional CCK receptors in rat brainEvaluation of brain penetration of CCK-B antagonists.Social defeat increases alcohol preference of C57BL/10 strain mice; effect prevented by a CCKB antagonist.Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.Concurrent chronic administration of a CCK(B) antagonist can decrease tolerance to the ataxic effects of ethanol.Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders.Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test.The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats.Gastrointestinal effects of diazepam-withdrawal are linked to activation of central cholecystokinin-ergic pathways in rats.Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites.Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs.
P2860
Q24673072-B2867498-AAE4-4816-A421-E3A3FF70C8BEQ24795177-EF0FDEE5-1DC3-4F2A-8A7A-0BB38213405FQ28345790-FA5F628F-0C2F-4D45-B9EC-316EB2963300Q30532041-62E9AE49-A9B7-40C4-B810-A61A2D3D479FQ33716278-C5AEDB5F-C721-4840-ADB0-FBF5CC7476C6Q34272451-3C0795AD-6602-4F47-82FD-3468FBAD46EDQ34420283-506F900E-E53E-48EA-8195-9E1403E48087Q36179745-CB36FF9B-A806-42EA-8A33-97BB17AF70B6Q36709407-B9CE7C56-173D-4F60-9316-7FAD16C417B4Q40753318-FC4F3D13-1C78-470D-BC6C-158FFACBFDC3Q42003959-BE6ECA7F-B551-46BE-A2DC-4CE241F975F5Q42132920-95BA3E62-6F44-4A71-81D9-F0F225B05C21Q42175984-5A2F700A-23C4-475C-8D34-596EA67A19C3Q46182383-534B81CD-AAD1-49F4-8735-58B29A68592EQ46736728-5ABA55E9-F2B8-4F8D-9C83-DA8254B66BFFQ48193560-2C97CA5B-4393-43F3-89A9-E759467E5397Q48318017-B137260B-6DC3-4550-9410-11CA3F63EB9DQ48660973-CE09C280-F39D-4105-9E69-A046F0C61E29Q48824361-5184CE70-A69D-4753-AA1B-0A9972077087Q48824499-790F28D6-D864-4840-A4B6-263354D6E52BQ51115170-4A836871-1C73-497C-8F71-4E622BE74C6FQ51121767-380F0AEF-31DE-4052-82B0-BE595542870CQ51624880-237DF151-84CC-453F-8429-0601AB84D623Q51654154-EB521EF7-99E9-4258-95D3-2B375E81AF7CQ52206236-D92B6811-1508-4EC1-A5B7-C4245362EA14
P2860
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
description
1991 nî lūn-bûn
@nan
1991 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
@ast
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
@en
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
@nl
type
label
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
@ast
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
@en
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
@nl
prefLabel
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
@ast
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
@en
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
@nl
P2093
P2860
P1476
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
@en
P2093
G N Woodruff
P2860
P304
P356
10.1111/J.1476-5381.1991.TB12413.X
P407
P577
1991-09-01T00:00:00Z